Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study

The treatment of glioblastoma multiforme (GBM) is challenging owing to its localization in the brain, the limited capacity of brain cells to repair, resistance to conventional therapy, and its aggressiveness. Curcumin has anticancer activity against aggressive cancers, such as leukemia, and GBM; how...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermawan, Adam, Wulandari, Febri, Hanif, Naufa, Utomo, Rohmad Yudi, Jenie, Riris Istighfari, Ikawati, Muthi, Tafrihani, Ahmad Syauqy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385707/
https://www.ncbi.nlm.nih.gov/pubmed/35977996
http://dx.doi.org/10.1038/s41598-022-18348-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385707/
https://www.ncbi.nlm.nih.gov/pubmed/35977996
http://dx.doi.org/10.1038/s41598-022-18348-9

Ejemplares similares